Actively Recruiting
Impact of P53 and SIRT1 in Type 2 Diabetes
Led by Sherief Abd-Elsalam · Updated on 2019-04-24
90
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
CONDITIONS
Official Title
Impact of P53 and SIRT1 in Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prediabetic subjects.
You will not qualify if you...
- Confirmed diabetes.
- Hepatic or renal impairment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Cairo, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here